← All patents

US20070004748A1

Inhibition of osteolytic lesions by SRC kinase inhibitors

University of Texas System

Abstract

The present invention include methods and compositions for treating bone-resorbing diseases or bone resorption related to a pathologic condition generally, including, but not limited to osteoporosis, arthritis, rheumatoid arthritis, cancer metastases to the bone, bone cancer, hypercalcemia, …

University
University of Texas System
Assignee
The Board Of Regents Of The University Of Texas System
Inventor
Bryant Darnay
Priority date
June 17, 2005
Filing date
June 16, 2006
Publication date
January 04, 2007
Language
en
Metadata fetched
August 29, 2026 00:18